Medication info
Ezet 10 mg Tablet (Ezetimibe)

Ezet 10 mg Tablet (Ezetimibe)

Prescription medicationTablet
Ingredient · strength
Ezetimibe›10mg / 1 tablet
Manufacturer / importer
Korea Hutech Pharmaceutical Co., Ltd.
Appearance
White to nearly white, elongated tablets
Packaging
30 tablets (10 tablets/PTP x 3)
Approval status
Active

MFDS item code 201701412 · Approved 2017.03.24 · Insurance code 649103400

Summary

Main use
Improvement of hypercholesterolemia, mixed hyperlipidemia, and homozygous sitosterolemia
Who uses it
Adults
Adult dosage
A standard cholesterol-lowering diet should be continued during treatment with this drug. The recommended dose of this drug is 10 mg once daily, with or without food. When this drug is administered concomitantly with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), initiate concomitant treatment with this drug at the recommended starting dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, administer this drug concomitantly while maintaining the dose of the HMG-CoA reductase inhibitor. When this drug is administered concomitantly with fenofibrate (in patients with mixed hyperlipidemia), administer it with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use, 4. General Precautions). 1. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Patients Requiring Careful Administration). 2. Administration to patients with renal impairment No dose adjustment is necessary in patients with renal impairment. 3. Administration to elderly patients No dose adjustment is necessary when administered to elderly patients. 4. Concomitant administration with bile acid sequestrants This drug should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use, 5. Interactions).

Ingredients

Manufacturer
Korea Hutech Pharmaceutical Co., Ltd.

Efficacy & effects

Improvement of hypercholesterolemia, mixed hyperlipidemia, and homozygous sitosterolemia

  • Primary hypercholesterolemia
  • elevated total cholesterol
  • low-density lipoprotein cholesterol
  • apolipoprotein B
  • mixed hyperlipidemia
  • non-high-density lipoprotein cholesterol
  • homozygous familial hypercholesterolemia
  • homozygous familial sitosterolemia
  • elevated sitosterol
  • campesterol
  • increased risk of atherosclerotic vascular disease due to hypercholesterolemia
  • dyslipidemia
View approved original text

This medication helps lower cholesterol levels in patients with primary hypercholesterolemia and mixed hyperlipidemia. It is especially effective in reducing elevated total cholesterol, low-density lipoprotein cholesterol (LDL-C), and apolipoprotein B (Apo B), and is used either alone or in conjunction with other lipid-lowering agents as an adjunct to dietary therapy. Additionally, in patients with homozygous familial hypercholesterolemia, it is used in combination with other lipid-lowering therapies to manage cholesterol levels. In cases of homozygous sitosterolemia, it aids in lowering plant sterol levels, enhancing therapeutic effects when combined with an appropriate diet. This medication is used when dietary therapy is insufficient in response after eliminating or managing secondary causes of dyslipidemia, with treatment guided by lipid testing results. Overall, this medication plays a crucial role in improving hypercholesterolemia and related dyslipidemic states.

Dosage and Administration

Adult dosage

A standard cholesterol-lowering diet should be continued during treatment with this drug. The recommended dose of this drug is 10 mg once daily, with or without food. When this drug is administered concomitantly with an HMG-CoA reductase inhibitor (in patients with primary hypercholesterolemia), initiate concomitant treatment with this drug at the recommended starting dose of the HMG-CoA reductase inhibitor. If the patient is already receiving a high dose of an HMG-CoA reductase inhibitor, administer this drug concomitantly while maintaining the dose of the HMG-CoA reductase inhibitor. When this drug is administered concomitantly with fenofibrate (in patients with mixed hyperlipidemia), administer it with fenofibrate 160mg once daily or 200mg once daily (see Precautions for Use, 4. General Precautions). 1. Administration to patients with hepatic impairment No dose adjustment is necessary in patients with mild hepatic impairment; however, use of this drug is not recommended in patients with moderate to severe hepatic impairment (see Precautions for Use, 2. Patients Requiring Careful Administration). 2. Administration to patients with renal impairment No dose adjustment is necessary in patients with renal impairment. 3. Administration to elderly patients No dose adjustment is necessary when administered to elderly patients. 4. Concomitant administration with bile acid sequestrants This drug should be administered at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant (see Precautions for Use, 5. Interactions).

Precautions

This medication should not be used in patients with an allergic reaction to its components. Co-administration with certain lipid-lowering agents is prohibited in patients with active liver disease or those with persistently elevated liver enzymes of unknown origin. Women who are pregnant or nursing should not use this medication together with certain lipid-lowering agents, and women of childbearing potential should exercise caution. Patients with severely impaired liver function or gallbladder disease should avoid co-administration with certain lipid-lowering agents. Patients with lactose intolerance should refrain from taking this medication due to its lactose content. In patients with moderate to severe liver impairment, the concentration of this medication in the body may increase, which may lead to unexpected side effects; therefore, it should be used with caution. This medication is generally well tolerated, but side effects such as headaches, abdominal pain, diarrhea, fatigue, arthralgia, low back pain, cough, dizziness, constipation, bloating, nausea, muscle pain, vomiting, gastritis, dry mouth, discomfort in the epigastric region, belching, gastrointestinal disturbances, gastroesophageal reflux disease, glossitis, palpitations, congestive heart failure, myocardial ischemia, flushing, sputum, runny nose, limb pain, diabetes, hypoglycemia, anemia, splenomegaly, sweating, rash, and itching may occur. Caution is advised when combining this medication with other lipid-lowering agents, as there may be a slight increase in the risk of elevated liver enzyme levels and muscle-related adverse reactions. If symptoms of musculoskeletal disorders such as myalgia, muscle weakness, or muscle damage occur, the patient should consult a physician immediately, and drug administration should be discontinued if necessary. Patients with severe renal impairment can use this medication without special dosage adjustments; however, caution is advised as renal impairment may increase the risk of myopathy. This medication may interact with specific drugs, so inform your doctor or pharmacist if you are taking other medications. Generally, it is advisable not to use this medication during pregnancy or breastfeeding, and if it is necessary, it should be carefully decided after consulting a specialist. Use is not recommended in children under 6 years of age, and in children over 6 years, pharmacokinetics are similar to adults, but data on long-term use are limited. It can generally be safely used in the elderly, but some elderly individuals may be more sensitive to side effects, so monitoring is required. There is no specific antidote for overdose, so appropriate treatment should be provided based on symptoms. This medication should be stored out of the reach of children and should not be transferred to other containers for safety.

Side effects

Fatigue, abdominal pain, diarrhea, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, chest pain, dizziness, headache, constipation, bloating, nausea, elevated AST, elevated ALT, myalgia, myopathy, rhabdomyolysis, hepatitis, thrombocytopenia, pancreatitis, sensory disturbances, depression, cholelithiasis, cholecystitis, mucocutaneous syndrome, toxic epidermal necrolysis, eosinophilia with systemic symptoms drug reaction, erythema multiforme, drug-induced liver injury, chest discomfort, edema, weakness, generalized edema, diabetic neuropathy, tremor, upper abdominal pain, vomiting, gastritis, dry mouth, epigastric discomfort, belching, gastrointestinal disorders, gastroesophageal reflux disease, tongue disorders, palpitations, congestive heart failure, myocardial ischemia, flushing, phlegm, runny nose, limb pain, diabetes, hypoglycemia, anemia, splenomegaly, urticaria, hyperhidrosis, rash, pruritus, upper respiratory tract infection, conjunctival injection, renal failure, liver dysfunction, increased blood serum creatinine, elevated blood pressure, increased blood urea, increased serum creatine phosphokinase, abnormal liver function tests, nausea

Not everyone experiences these, and they can vary from person to person.

Storage

This medication is sensitive to air and moisture, so it should be stored in a tightly sealed container at cool room temperature. It is important to maintain the storage temperature between 1 degree Celsius and 30 degrees Celsius.

Appearance and packaging

Appearance

White to nearly white, elongated tablets

Package unit

30 tablets (10 tablets/PTP x 3)

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.